You are here: Industry Insights > coronavirus

News List

Emergent BioSolutions Initiates Development of Plasma-Derived Candidates Coronavirus americanpharmaceuticalreview
March 18, 2020
Emergent BioSolutions has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19).
CEPI calls for $2bn of funding for coronavirus vaccine europeanpharmaceuticalreview
March 18, 2020
According to CEPI, $2 billion is needed to progress coronavirus vaccines through development as quickly as possible, leading the organisation to call for donations.
FDA Updates Coronavirus Policy contractpharma
March 18, 2020
Policy addresses labs and commercial manufacturers to expand the number and variety of diagnostic tests to achieve more rapid testing capacity in the U.S.
Celltex to study mesenchymal stem cells for coronavirus treatment pharmaceutical-technology
March 18, 2020
Celltex Therapeutics has initiated talks with the US Food and Drug Administration (FDA) to conduct a study of adult, autologous mesenchymal stem cells (MSCs) for the treatment of Covid-19 symptoms.
J&J says no evidence darunavir works against coronavirus pharmaceutical-technology
March 18, 2020
Johnson and Johnson (J&J) have noted the lack of evidence that its HIV drug darunavir has antiviral activity against SARS-CoV-2, the novel coronavirus that causes Covid-19.
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus prnewswire
March 18, 2020
EmphyCorp Inc., a Private Corporation, is proud to announce that EmphyCorp Rx N115 Non-Steroidal Nasal Spray with no known side effects for Pulmonary Fibrosis, Cystic Fibrosis ...
Pfizer, BioNTech to co-develop potential coronavirus vaccine expresspharma
March 18, 2020
US drugmaker Pfizer has signed a deal with Germany’s BioNTech to co-develop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform.
Roche's cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization worldpharmanews
March 17, 2020
Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test.
New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus worldpharmanews
March 17, 2020
CRISPR-based genetic screens have helped scientists identify genes that are key players in sickle-cell anemia, cancer immunotherapy, lung cancer metastasis, and many other diseases.
CureVac works on mRNA vaccine for coronavirus pharmaceutical-technology
March 17, 2020
German biopharmaceutical company CureVac is working on the development of an mRNA-based vaccine to protect against Covid-19 coronavirus infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page